generics

Market consolidation, AI-driven innovation, and supportive government policies are set to propel India's pharma industry toward…

Dr Suresh Saravdekar, Ex-Assistant Director, Ministry of Medical Education and Health, State of Maharashtra and Ex-honorary…

The strategy is likely to improve the regulatory and decision-making aspects related to pharmaceutical products

There is no patent yet on the experimental candidate PF-07321332, and ritonavir has been off-patent since last year

Everolimus (Afinitor) is a prescription medication that is used to treat certain types of cancers and tumours

The company is amongst the first to receive permission from DCGI and launch the drug in India

Pursuant to the terms of the settlement, Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture…

Rishabh Bindlish, MD, India Life Sciences and Global Generics Lead, Accenture in India talks about the measures needed to revive…

Abhinav Bhatia, Enterprise Ireland’s recently appointed Director for India and South Asian regions highlights the benefits and…

Korean pharmaceutical exports have become attractive due to competitive pricing in the generics market and, as a result, Korean…